|
Volumn 24, Issue 4, 2011, Pages 1099-1101
|
Rheumatoid arthritis: A complication of aromatase inhibitor therapy?
|
Author keywords
Aromatase inhibitors; Breast cancer; RANKL; Rheumatoid arthritis
|
Indexed keywords
ANASTROZOLE;
BISPHOSPHONIC ACID DERIVATIVE;
C REACTIVE PROTEIN;
METHOTREXATE;
MONOCYTE CHEMOTACTIC PROTEIN 2;
MONOCYTE CHEMOTACTIC PROTEIN 3;
OSTEOCLAST DIFFERENTIATION FACTOR;
PREDNISOLONE;
RHEUMATOID FACTOR;
TAMOXIFEN;
VITAMIN D;
METHYLPREDNISOLONE;
ADULT;
ARTHRALGIA;
ARTICLE;
BONE DENSITY;
BONE SCINTISCANNING;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURGERY;
CASE REPORT;
DISEASE SEVERITY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
FEMUR NECK;
HUMAN;
JOINT STIFFNESS;
JOINT SWELLING;
MORNING STIFFNESS;
OSTEOPOROSIS;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RHEUMATOID ARTHRITIS;
TH1 CELL;
TH2 CELL;
TREATMENT DURATION;
X RAY;
BIOCHEMICAL ANALYSIS;
MIDDLE AGED;
REMISSION;
SEGMENTAL MASTECTOMY;
|
EID: 84856563743
PISSN: 03946320
EISSN: None
Source Type: Journal
DOI: 10.1177/039463201102400430 Document Type: Article |
Times cited : (7)
|
References (8)
|